FindTrial
Sign In

Use of Alpha-Blockers Before RIRS: Assessment of Factors for Successful Ureteral Access Sheath Insertion. A Randomized Clinical Study

Use of Alpha-Blockers Before RIRS: Assessment of Factors for Successful Ureteral Access Sheath Insertion. A Randomized Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112953
Enrollment
Unknown
Registered
2025-11-21
Start date
2021-07-14
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urolithiasis

Interventions

I (Tamsulosin):Non-prestented patients receiving 0.4 mg of Tamsulosin daily for 7 days before RIRS.
II (Silodosin):Non-prestented patients receiving 8 mg of Silodosin daily for 7 days before RIRS.
III:Prestented patients before RIRS
IV:Non-prestented patient

Sponsors

St. Luke’s Clinical Hospital Russian Federation
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over 18 years with renal stones up to 2 cm in size, density above 1000 HU, and no pathogenic flora in urine culture

Exclusion criteria

Exclusion criteria: ?ongenital anomalies of the urinary tract, urinary tract infections, upper urinary tract obstruction, or prior reconstructive surgeries on the upper urinary tract.

Design outcomes

Primary

MeasureTime frame
Pain syndrome;Success of ureteral access sheath placement;Operative time;?omplications;Degree of ureteral injury ;Factors influencing successful ureteral access sheath placement;Inflammatory changes in blood tests;—

Countries

Russia

Contacts

Public ContactDmitriy Sytnik

Urologist of department of urology ?1 of St. Luke Clinical Hospital, Saint-Petersburg, Russian Federation

doc.dmitriysytnik@gmail.com+7 931 367 78 58

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026